Julio Raúl Fernández Massó

4PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 06, 2026
In vivo evaluation of the antitumor peptide CIGB-552: antitumor activity, pharmacokinetics and safety of the subcutaneously administered peptide.

Nivaldo Angel Gómez Hernández, Luis Miguel Martínez Durán, Héctor Santana Milian

|Jan 30, 2022
Synergic effect of anticancer peptide CIGB-552 and Cisplatin in lung cancer models.

Yolanda Gomez Rodriguez, Brizaida Oliva Arguelles, Mario Riera-Romo

|Jan 05, 2021
The Anticancer Peptide CIGB-552 Exerts Anti-Inflammatory and Anti-Angiogenic Effects through COMMD1.

Hellen Daghero, Julio Raúl Fernández Massó, Soledad Astrada

|Mar 31, 2018
Cell Penetrating Capacity and Internalization Mechanisms Used by the Synthetic Peptide CIGB-552 and Its Relationship with Tumor Cell Line Sensitivity.

Soledad Astrada, Julio Raúl Fernández Massó, Maribel G Vallespí

Pageof 1